VIATRIS INC. Diluted Shares Outstanding (Weighted Average)
VIATRIS INC. (VTRS) reported Diluted Shares Outstanding (Weighted Average) of 1.16 billion shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- VIATRIS INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 1.16B shares, a 0.83% decline year-over-year.
- VIATRIS INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 1.18B shares, a 1.43% decline year-over-year.
- VIATRIS INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 1.16B shares, a 2.98% decline year-over-year.
- VIATRIS INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 1.17B shares, a 1.52% decline year-over-year.
- VIATRIS INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 1.21B shares, a 0.86% decline from fiscal 2022.
- VIATRIS INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 1.22B shares, a 0.71% increase from fiscal 2021.
- VIATRIS INC. weighted average number of shares outstanding, diluted for fiscal 2021 was 1.21B shares, a 101.06% increase from fiscal 2020.
- VIATRIS INC. weighted average number of shares outstanding, diluted for fiscal 2020 was 601.20M shares, a 16.40% increase from fiscal 2019.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.16B shares 10-Q · filed 2026-08-06 | 1.17B shares 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 1.18B shares 10-Q · filed 2026-05-07 | |||
| 2025-09-30 | 1.16B shares 10-Q · filed 2025-11-06 | 1.17B shares derived: average of 2 quarters · filed 2026-08-06 | 1.18B shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 1.17B shares 10-Q · filed 2026-08-06 | 1.18B shares 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 1.19B shares 10-Q · filed 2026-05-07 | |||
| 2024-09-30 | 1.20B shares 10-Q · filed 2025-11-06 | 1.20B shares derived: average of 2 quarters · filed 2025-11-06 | 1.19B shares 10-Q · filed 2025-11-06 | 1.20B shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 1.19B shares 10-Q · filed 2025-08-07 | 1.19B shares 10-Q · filed 2025-08-07 | 1.20B shares derived: average of 3 quarters · filed 2026-02-26 | 1.20B shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 1.21B shares 10-Q · filed 2025-05-08 | 1.21B shares derived: average of 2 quarters · filed 2026-02-26 | 1.21B shares derived: average of 3 quarters · filed 2026-02-26 | 1.21B shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 1.21B shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 1.21B shares derived: average of 2 quarters · filed 2026-02-26 | 1.21B shares derived: average of 3 quarters · filed 2026-02-26 | 1.21B shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 1.21B shares 10-Q · filed 2024-11-07 | 1.21B shares derived: average of 2 quarters · filed 2024-11-07 | 1.21B shares 10-Q · filed 2024-11-07 | 1.21B shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 1.20B shares 10-Q · filed 2024-08-08 | 1.20B shares 10-Q · filed 2024-08-08 | 1.21B shares derived: average of 3 quarters · filed 2025-02-27 | 1.21B shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 1.21B shares 10-Q · filed 2024-05-09 | 1.21B shares derived: average of 2 quarters · filed 2025-02-27 | 1.22B shares derived: average of 3 quarters · filed 2025-02-27 | 1.22B shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 1.22B shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 1.22B shares derived: average of 2 quarters · filed 2025-02-27 | 1.22B shares derived: average of 3 quarters · filed 2025-02-27 | 1.22B shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 1.22B shares 10-Q · filed 2022-11-07 | 1.22B shares derived: average of 2 quarters · filed 2023-08-07 | 1.22B shares 10-Q · filed 2023-11-08 | 1.21B shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | 1.22B shares 10-Q · filed 2023-08-07 | 1.22B shares 10-Q · filed 2023-08-07 | 1.21B shares derived: average of 3 quarters · filed 2024-02-28 | 1.21B shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | 1.21B shares 10-Q · filed 2023-05-08 | 1.21B shares derived: average of 2 quarters · filed 2024-02-28 | 1.21B shares derived: average of 3 quarters · filed 2024-02-28 | 1.21B shares derived: average of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | 1.21B shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 1.21B shares derived: average of 2 quarters · filed 2024-02-28 | 1.21B shares derived: average of 3 quarters · filed 2024-02-28 | 1.21B shares 10-K · filed 2024-02-28 |
| 2021-09-30 | 1.21B shares 10-Q · filed 2022-11-07 | 1.21B shares derived: average of 2 quarters · filed 2022-11-07 | 1.21B shares 10-Q · filed 2022-11-07 | 1.12B shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | 1.21B shares 10-Q · filed 2022-08-08 | 1.21B shares 10-Q · filed 2022-08-08 | 1.09B shares derived: average of 3 quarters · filed 2023-02-27 | 946.73M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | 1.21B shares 10-Q · filed 2022-05-09 | 1.03B shares derived: average of 2 quarters · filed 2023-02-27 | 859.37M shares derived: average of 3 quarters · filed 2023-02-27 | 773.83M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | 852.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 685.30M shares derived: average of 2 quarters · filed 2023-02-27 | 629.27M shares derived: average of 3 quarters · filed 2023-02-27 | 601.20M shares 10-K · filed 2023-02-27 |
| 2020-09-30 | 517.70M shares 10-Q · filed 2021-11-08 | 517.45M shares derived: average of 2 quarters · filed 2021-11-08 | 517.30M shares 10-Q · filed 2021-11-08 | |
| 2020-06-30 | 517.20M shares 10-Q · filed 2021-08-09 | 517.10M shares 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | 517.00M shares 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | 516.50M shares 10-K · filed 2022-02-28 | |||
| 2018-12-31 | 516.50M shares 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |